Recommendations from the Spanish Oncology Genitourinary Group for the treatment of metastatic renal cancer
- 4 March 2009
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 63 (S1) , 1-13
Abstract
For almost the last two decades, interleukin-2 and interferon-α have been the only systemic treatment options available for metastatic renal cell carcinoma. However, in recent years, five new targeted therapies namely sunitinib, sorafenib, temsirolimus, everolimus and bevacizumab have demonstrated clinical activity in these patients. With the availability of new targeted agents that are active in this disease, there is a need to continuously update the treatment algorithm of the disease. Due to the important advances obtained, the Spanish Oncology Genitourinary Group (SOGUG) has considered it would be useful to review the current status of the disease, including the genetic and molecular biology factors involved, the current predicting models for development of metastases as well as the role of surgery, radiotherapy and systemic therapies in the early- or late management of the disease. Based on this previous work, a treatment algorithm was developed.Keywords
This publication has 74 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Medroxyprogesterone, interferon alfa‐2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosisCancer, 2007
- Innovations and Challenges in Renal Cell Carcinoma: Summary Statement from the Second Cambridge ConferenceClinical Cancer Research, 2007
- Patients with Metastatic Renal Cell Carcinoma with Long-Term Disease-Free Survival After Treatment with Sunitinib and Resection of Residual MetastasesClinical Genitourinary Cancer, 2006
- New horizons in the treatment of renal cell cancerAnnals of Oncology, 2006
- Genetic and Epigenetic Analysis of von Hippel-Lindau (VHL) Gene Alterations and Relationship with Clinical Variables in Sporadic Renal CancerCancer Research, 2006
- Risk factors for adult renal cell carcinomaUrologic Clinics of North America, 2004
- Obesity, Hypertension, and the Risk of Kidney Cancer in MenNew England Journal of Medicine, 2000
- Risk factors for adult renal cell carcinoma: a systematic review and implications for preventionBJU International, 2000
- Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen renal cancer study groupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1987